Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Immunology and Cell Biology
|
April 23, 2014
Response to the letter to the editor
Nima Etemadi, John Silke, Ueli Nachbur
Mediators of Inflammation
|
June 14, 2017
Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer
Riley J Morrow, Nima Etemadi, Belinda Yeo, et al.
Immunology and Cell Biology
|
October 9, 2013
Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1
Nima Etemadi, Andrew Webb, Aleksandra Bankovacki, et al.
Seminars in Cancer Biology
|
June 26, 2017
The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
Jennifer Huynh, Nima Etemadi, Frédéric Hollande, et al.
The FEBS Journal
|
July 3, 2013
Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor
Nima Etemadi, Jessica K Holien, Diep Chau, et al.
Nature Communications
|
June 23, 2019
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
Moritz F Eissmann, Christine Dijkstra, Andrew Jarnicki, et al.
Cell Death & Disease
|
April 2, 2022
The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL
Annette V Jacobsen, Catia L Pierotti, Kym N Lowes, et al.
Gastroenterology
|
November 28, 2016
Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells
Thomas Grabinger, Konstantin J Bode, Janine Demgenski, et al.
Cell Death and Differentiation
|
April 29, 2020
Targeting triple-negative breast cancers with the Smac-mimetic birinapant
Najoua Lalaoui, Delphine Merino, Goknur Giner, et al.
Cell Death and Differentiation
|
January 21, 2017
Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways
Maria C Tanzer, Nufail Khan, James A Rickard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Immunology and Cell Biology
|
April 23, 2014
Response to the letter to the editor
Nima Etemadi, John Silke, Ueli Nachbur
Mediators of Inflammation
|
June 14, 2017
Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer
Riley J Morrow, Nima Etemadi, Belinda Yeo, et al.
Immunology and Cell Biology
|
October 9, 2013
Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1
Nima Etemadi, Andrew Webb, Aleksandra Bankovacki, et al.
Seminars in Cancer Biology
|
June 26, 2017
The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
Jennifer Huynh, Nima Etemadi, Frédéric Hollande, et al.
The FEBS Journal
|
July 3, 2013
Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor
Nima Etemadi, Jessica K Holien, Diep Chau, et al.
Nature Communications
|
June 23, 2019
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
Moritz F Eissmann, Christine Dijkstra, Andrew Jarnicki, et al.
Cell Death & Disease
|
April 2, 2022
The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL
Annette V Jacobsen, Catia L Pierotti, Kym N Lowes, et al.
Gastroenterology
|
November 28, 2016
Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells
Thomas Grabinger, Konstantin J Bode, Janine Demgenski, et al.
Cell Death and Differentiation
|
April 29, 2020
Targeting triple-negative breast cancers with the Smac-mimetic birinapant
Najoua Lalaoui, Delphine Merino, Goknur Giner, et al.
Cell Death and Differentiation
|
January 21, 2017
Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways
Maria C Tanzer, Nufail Khan, James A Rickard, et al.
Page
of 2